Charles W. Patrick
Corporate Officer/Principal bei Patrick Consulting Ltd.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Mara Aspinall | F | 61 | 7 Jahre | |
| Jim Datin | M | 61 | 5 Jahre | |
| David Shulkin | M | 64 | 4 Jahre | |
| Karen Drexler | F | 64 | 14 Jahre | |
| Elizabeth Ann Hutt Pollard | F | 57 | 9 Jahre | |
| Michele Anthony | F | 50 | 17 Jahre | |
| David A. Rappaport | M | - | 6 Jahre | |
| Kathleen Weber | F | 57 | 12 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Patrick Plewman | M | 58 |
VaxGen, Inc.
 VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA.
diaDexus, Inc. /Old/
 diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | 11 Jahre |
| David J. Foster | M | 66 |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field.
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | 4 Jahre |
| James Panek | M | 71 |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | 4 Jahre |
| Stephen Tang | M | 63 | 11 Jahre | |
| Brian E. Ward | M | 71 | 4 Jahre | |
| Louis C. Bock | M | 59 |
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA.
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | 11 Jahre |
| Bernard Michael Alfano | M | 63 |
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA.
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | - |
| Ronald Spair | M | 58 | 17 Jahre | |
| Michael Celano | M | 65 | 16 Jahre | |
| Robert L. Wolfert | M | 70 |
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA.
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | 11 Jahre |
| Douglas Michels | M | 66 | 14 Jahre | |
| Gerald Ostrov | M | 73 | 3 Jahre | |
| Roberto Cuca | M | 57 | 3 Jahre | |
| Anthony Zezzo | M | 70 | 9 Jahre | |
| James Sulat | M | 73 | 1 Jahre | |
| Douglas G. Watson | M | 79 | 14 Jahre | |
| Christopher Lowe | M | 56 | - | |
| Sarah Schiltz | F | - | 4 Jahre | |
| Adeoye Olukotun | M | 79 | 2 Jahre | |
| Eamonn Hobbs | M | 65 | 6 Jahre | |
| Eric Whitters | M | - | - | |
| Alexander Johnson | M | - | 1 Jahre | |
| Andrew Galligan | M | 67 | 5 Jahre | |
| Aradhana Sarin | M | 50 | - | |
| Debra Y. Fraser-Howze | F | - | - | |
| Lori F. Rafield | M | 69 |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field.
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | 2 Jahre |
| Nancy J. McLane | F | - | - | |
| Roger L. Pringle | M | 83 | 17 Jahre | |
| Henry B. Cohen | M | - | 10 Jahre | |
| Scott F. Large | M | - |
University of Central Florida
| 4 Jahre |
| Robert J. Schott | M | - | - | |
| Brian L. Smith | M | - | - | |
| Brian W. Reid | M | - | - | |
| Patrick Arensdorf | M | - | - | |
| Roberto Macina | M | - |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | - |
| Kenneth Charles Fang | M | 61 | - | |
| Robert A. Gregg | M | - | - | |
| Scott Alan Hutchinson | M | 68 |
University of Central Florida
| 4 Jahre |
| Jeanne Mell | F | - | 3 Jahre | |
| E. Ralf Schoenbrunner | M | - | - | |
| Rene M. Reed | M | 76 |
University of Central Florida
| 4 Jahre |
| Paul Manners | M | - | - | |
| Bill Trahan | M | - |
University of Central Florida
| 4 Jahre |
| David Wm. Boone | M | - |
University of Central Florida
| 4 Jahre |
| Jill Thompson | F | - | 5 Jahre | |
| Kenneth H. Adams | M | 73 |
University of Central Florida
| 4 Jahre |
| Michael Reed | M | 55 | 4 Jahre | |
| Joni Messenlehner | M | - | 5 Jahre | |
| Rolddy Leyva | M | - |
University of Central Florida
| 4 Jahre |
| Lisa Nibauer | F | 56 | 2 Jahre | |
| Alexander Johnson | M | 50 | 1 Jahre | |
| Daniel J. Dunham | M | - |
University of Central Florida
| 4 Jahre |
| Richard Walsh | M | 72 |
University of Central Florida
| 4 Jahre |
| James Ted Rauth | M | 59 | 3 Jahre | |
| Thomas M. Watlington | M | 68 |
Alere San Diego, Inc.
 Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | 7 Jahre |
| Felix Baker | M | 55 |
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | - |
| Glenn R. Padgett | M | 73 |
University of Central Florida
| 4 Jahre |
| Laurette Koellner | F | 69 |
University of Central Florida
| 4 Jahre |
| John Apeler Keller | M | 60 |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | 7 Jahre |
| Franklin Berger | M | 74 |
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | 7 Jahre |
| Mark L. Kuna | M | 60 | 18 Jahre | |
| Christopher Twomey | M | 64 |
Alere San Diego, Inc.
Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | 17 Jahre |
| Peter Witerzens | M | - |
Alere San Diego, Inc.
Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | - |
| Stephen R. Lee | M | 64 | 9 Jahre | |
| Jeffrey Moy | M | 63 |
Alere San Diego, Inc.
Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | 9 Jahre |
| Emilia Bulaevsky Zychlinsky | M | 68 | 5 Jahre | |
| Robert Michael Richey | M | 71 | 3 Jahre | |
| Thomas H. Adams | M | 81 |
Alere San Diego, Inc.
Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | 9 Jahre |
| Craig S. Miller | M | 75 |
University of Central Florida
| 3 Jahre |
| Joseph E. Zack | M | 72 | 6 Jahre | |
| David W. Nikka | M | 69 | 2 Jahre | |
| Samuel L. Lupfer | M | 68 |
University of Central Florida
| 4 Jahre |
| G. Mark Kirtland | M | 62 | 4 Jahre | |
| William J. Ferenczy | M | - |
Alere San Diego, Inc.
Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | - |
| John Cajigas | M | 58 |
Alere San Diego, Inc.
Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | 12 Jahre |
| Stephen M. Lesefko | M | - |
Alere San Diego, Inc.
Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | - |
| Paul H. McPherson | M | - |
Alere San Diego, Inc.
Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | - |
| S. Elaine Walton | F | - |
Alere San Diego, Inc.
Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | - |
| Jean-Frédéric Viret | M | 58 | 2 Jahre | |
| Kelvin Neu | M | 50 |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | 5 Jahre |
| E. A. Stacey Olliff | M | - |
University of Central Florida
| 4 Jahre |
| Jack Goldstein | M | 77 | 5 Jahre | |
| Richard B. Lanman | M | 69 |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | 3 Jahre |
| Michael Goller | M | 49 |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | 5 Jahre |
| Jeffrey Thompson | M | - |
University of Central Florida
| 4 Jahre |
| Melissa Barron | F | 43 | 12 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 94 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Charles W. Patrick
- Persönliches Netzwerk
